Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 8:43 PM UTC
| NCT Number | NCT06492616 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 4,220 participants |
| Active Locations | 176 sites in the US |
| Sponsor | Stemline Therapeutics, Inc. |
| Last Updated on CT.gov | September 15, 2026 (Sep 15, 2026) |
As of October 16, 2026: Clinical trial NCT06492616 is currently recruiting participants. This phase3 study for breast cancer is actively seeking new participants at 176 locations across the United States. The study is sponsored by Stemline Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06492616 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 176 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06492616 was last updated Sep 15, 2026 (September 15, 2026). HelloStudys verifies this status automatically.